{
    "2021-04-09": [
        [
            {
                "time": "2023-10-01",
                "original_text": "毛利与净利双升！一个更具成长性的“CXO老二”？",
                "features": {
                    "keywords": [
                        "毛利",
                        "净利",
                        "双升",
                        "成长性",
                        "CXO"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "两市百元股数量达134只，医药生物行业占比最高",
                "features": {
                    "keywords": [
                        "百元股",
                        "数量",
                        "医药生物",
                        "占比最高"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}